HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Giuseppe Fiume Selected Research
Giuseppe Fiume Research Topics
Disease
22
Neoplasms (Cancer)
01/2024 - 12/2009
5
Lymphoma (Lymphomas)
01/2024 - 01/2015
4
Melanoma (Melanoma, Malignant)
05/2021 - 11/2019
4
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021 - 11/2019
4
Infections
01/2019 - 12/2004
3
Inflammation (Inflammations)
06/2022 - 09/2015
3
Carcinogenesis
01/2021 - 05/2011
3
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2019 - 08/2008
2
B-Cell Lymphoma (Lymphoma, B Cell)
02/2022 - 01/2015
2
Disease Progression
01/2018 - 10/2017
2
Carcinoma (Carcinomatosis)
03/2014 - 05/2011
2
Acquired Immunodeficiency Syndrome (AIDS)
12/2007 - 12/2004
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2024
1
Triple Negative Breast Neoplasms
01/2023
1
Hypertension (High Blood Pressure)
01/2023
1
Essential Hypertension
01/2023
1
Bites and Stings (Sting)
11/2022
1
Thyroid Neoplasms (Thyroid Cancer)
08/2022
1
Burkitt Lymphoma (Burkitt's Lymphoma)
02/2022
1
Bronchial Hyperreactivity
01/2020
1
Lung Injury
01/2020
1
Hypersensitivity (Allergy)
01/2020
1
Vesicular Stomatitis
01/2019
1
Multiple Myeloma
10/2017
1
Necrosis
01/2017
1
Residual Neoplasm
01/2015
1
Seizures (Absence Seizure)
11/2014
1
Absence Epilepsy (Childhood Absence Epilepsy)
11/2014
1
Neuroinflammatory Diseases
11/2014
1
Breast Neoplasms (Breast Cancer)
05/2011
1
Chromosome Aberrations (Chromosome Abnormalities)
08/2008
Drug/Important Bio-Agent (IBA)
9
Proteins (Proteins, Gene)
FDA Link
11/2022 - 08/2008
8
Peptides (Polypeptides)
IBA
01/2023 - 03/2014
4
Antigens
IBA
01/2021 - 05/2011
4
Cytokines
IBA
01/2020 - 11/2014
3
Ligands
IBA
01/2023 - 01/2021
3
Messenger RNA (mRNA)
IBA
01/2023 - 02/2022
3
MicroRNAs (MicroRNA)
IBA
01/2023 - 12/2009
3
Conditioned Culture Media
IBA
06/2022 - 01/2017
3
immunoglobulin B
IBA
01/2021 - 10/2017
3
Epitopes
IBA
01/2020 - 05/2011
2
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
06/2022 - 01/2017
2
Tumor Biomarkers (Tumor Markers)
IBA
08/2020 - 01/2014
2
Agammaglobulinaemia Tyrosine Kinase
IBA
01/2018 - 05/2015
2
Biomarkers (Surrogate Marker)
IBA
10/2017 - 01/2014
2
Monoclonal Antibodies
IBA
03/2014 - 05/2011
2
Vaccines
IBA
03/2014 - 07/2008
1
Rituximab (Mabthera)
FDA Link
01/2024
1
Progesterone Receptors (Progesterone Receptor)
IBA
01/2023
1
Salts
IBA
01/2023
1
human ERBB2 protein
IBA
01/2023
1
ErbB Receptors (EGF Receptor)
IBA
01/2023
1
Estrogens (Estrogen)
FDA Link
01/2023
1
Cyclic Peptides
IBA
01/2023
1
OVA-8
IBA
11/2022
1
Viral DNA
IBA
11/2022
1
Indicators and Reagents (Reagents)
IBA
08/2022
1
Uridine Diphosphate (UDP)
IBA
01/2021
1
Ions
IBA
01/2021
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2021
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2020
1
Chemokines
IBA
01/2020
1
5'-Nucleotidase (5' Nucleotidase)
IBA
01/2020
1
Allergens
IBA
01/2020
1
Immunoglobulin E (IgE)
IBA
01/2020
1
Ovalbumin
IBA
01/2020
1
Immunologic Factors (Immunomodulators)
IBA
01/2020
1
Adenosine Triphosphate (ATP)
IBA
01/2020
1
Adenosine (Adenocard)
FDA Link
Generic
01/2020
1
Enzymes
IBA
01/2020
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
11/2019
1
sialic acid transport proteins
IBA
01/2019
1
anti-IgM
IBA
01/2019
1
zinc-binding protein (zinc binding protein)
IBA
01/2019
1
fludarabine
IBA
01/2018
1
Fluorescein-5-isothiocyanate (FITC)
IBA
10/2017
1
Paraproteins
IBA
10/2017
1
Cytostatic Agents
IBA
01/2017
1
Protein Isoforms (Isoforms)
IBA
05/2015
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2015
1
Small Interfering RNA (siRNA)
IBA
01/2015
1
Antineoplastic Agents (Antineoplastics)
IBA
01/2015
1
Lipopolysaccharides
IBA
11/2014
1
Neuroprotective Agents
IBA
11/2014
1
Sirolimus (Rapamycin)
FDA Link
11/2014
1
Antibodies
IBA
03/2014
1
Leukosialin
IBA
03/2014
1
Peptide Library
IBA
03/2014
1
Glycosyltransferases
IBA
01/2014
1
Polysaccharides (Glycans)
IBA
01/2014
1
Glycoside Hydrolases (Endoglycosidases)
IBA
01/2014
1
Trans-Activators (Trans-Acting Factor)
IBA
04/2012
1
Glycoproteins (Glycoprotein)
IBA
05/2011
1
NF-KappaB Inhibitor alpha
IBA
12/2007
1
NF-kappa B (NF-kB)
IBA
12/2004
Therapy/Procedure
13
Therapeutics
01/2024 - 12/2007
2
Immunotherapy
01/2021 - 03/2014
1
Drug Therapy (Chemotherapy)
01/2018
1
Precision Medicine
10/2017
1
Radiotherapy
01/2015